Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 492

1.

Difference in neointimal coverage at chronic stage between bare metal stent and sirolimus-eluting stent evaluated at stent-strut level by optical coherence tomography.

Ikuta S, Kobuke K, Iwanaga Y, Nakauchi Y, Yamaji K, Miyazaki S.

Heart Vessels. 2014 May;29(3):320-7. doi: 10.1007/s00380-013-0376-4.

PMID:
23793881
2.

Initial findings of impact of strut width on stent coverage and apposition of sirolimus-eluting stents assessed by optical coherence tomography.

Nakatani S, Nishino M, Taniike M, Makino N, Kato H, Egami Y, Shutta R, Tanouchi J, Yamada Y.

Catheter Cardiovasc Interv. 2013 Apr;81(5):776-81. doi: 10.1002/ccd.24401.

PMID:
22517601
3.

Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography.

Li S, Gai L, Yang T, Zhang L, Xu X, Bai Q, Xu H, Wang Y.

Catheter Cardiovasc Interv. 2013 Apr;81(5):768-75. doi: 10.1002/ccd.24497.

PMID:
22639418
4.

Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.

Guagliumi G, Musumeci G, Sirbu V, Bezerra HG, Suzuki N, Fiocca L, Matiashvili A, Lortkipanidze N, Trivisonno A, Valsecchi O, Biondi-Zoccai G, Costa MA; ODESSA Trial Investigators..

JACC Cardiovasc Interv. 2010 May;3(5):531-9. doi: 10.1016/j.jcin.2010.02.008.

5.

Optical coherence tomographic comparison of neointimal coverage between sirolimus- and resolute zotarolimus-eluting stents at 9 months after stent implantation.

Kim JS, Kim JS, Shin DH, Kim BK, Ko YG, Choi D, Jang Y, Hong MK.

Int J Cardiovasc Imaging. 2012 Aug;28(6):1281-7. doi: 10.1007/s10554-011-9943-x.

PMID:
21858655
6.

Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.

Poerner TC, Otto S, Gassdorf J, Nitsche K, Janiak F, Scheller B, Goebel B, Jung C, Figulla HR.

Circ Cardiovasc Interv. 2014 Dec;7(6):760-7. doi: 10.1161/CIRCINTERVENTIONS.113.001146.

7.

Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.

Fujino Y, Attizzani GF, Bezerra HG, Wang W, Tahara S, Yamamoto H, Chamie D, Kanaya T, Mehanna E, Takagi K, Nakamura S, Costa MA.

JACC Cardiovasc Interv. 2013 Oct;6(10):1035-45. doi: 10.1016/j.jcin.2013.05.015.

8.

Neointimal coverage of zotarolimus-eluting stent at 1, 2, and 3 months' follow-up: an optical coherence tomography study.

Hashikata T, Tojo T, Namba S, Kitasato L, Hashimoto T, Kameda R, Shimohama T, Yamaoka-Tojo M, Ako J.

Heart Vessels. 2016 Feb;31(2):206-11. doi: 10.1007/s00380-014-0598-0.

PMID:
25362579
9.

Tissue coverage of paclitaxel and sirolimus eluting stents in long term follow-up: optical coherence tomography study.

Kochman J, Pietrasik A, Rdzanek A, Ścibisz A, Pawlak M, Filipiak KJ, Opolski G.

Cardiol J. 2013;20(3):247-53. doi: 10.5603/CJ.2013.0069.

10.

Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography.

Chen BX, Ma FY, Luo W, Ruan JH, Xie WL, Zhao XZ, Sun SH, Guo XM, Wang F, Tian T, Chu XW.

Heart. 2008 May;94(5):566-70.

11.

Favorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: comparison with sirolimus-eluting stent using optical coherence tomography.

Choi HH, Kim JS, Yoon DH, Hong KS, Kim TH, Kim BK, Ko YG, Choi D, Jang Y, Hong MK.

Int J Cardiovasc Imaging. 2012 Mar;28(3):491-7. doi: 10.1007/s10554-011-9849-7.

PMID:
21442265
12.

Strut coverage and vessel wall response to zotarolimus-eluting and bare-metal stents implanted in patients with ST-segment elevation myocardial infarction: the OCTAMI (Optical Coherence Tomography in Acute Myocardial Infarction) Study.

Guagliumi G, Sirbu V, Bezerra H, Biondi-Zoccai G, Fiocca L, Musumeci G, Matiashvili A, Lortkipanidze N, Tahara S, Valsecchi O, Costa M.

JACC Cardiovasc Interv. 2010 Jun;3(6):680-7. doi: 10.1016/j.jcin.2010.04.005.

13.

Very long-term follow-up of strut apposition and tissue coverage with Biolimus A9 stents analyzed by optical coherence tomography.

Staico R, Costa MA, Chamié D, Bezerra H, Armaganijan LV, Costa RA, Costa JR, Siqueira D, Centemero M, Chaves Á, Tanajura LF, Abizaid A, Feres F, Sousa JE, Sousa AG.

Int J Cardiovasc Imaging. 2013 Jun;29(5):977-88. doi: 10.1007/s10554-013-0188-8.

PMID:
23456358
15.

First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).

Ormiston J, Webster M, Stewart J, Vrolix M, Whitbourn R, Donohoe D, Knape C, Lansky A, Attizzani GF, Fitzgerald P, Kandzari DE, Wijns W.

JACC Cardiovasc Interv. 2013 Oct;6(10):1026-34. doi: 10.1016/j.jcin.2013.05.013.

16.

Early vascular healing with rapid breakdown biodegradable polymer sirolimus-eluting versus durable polymer everolimus-eluting stents assessed by optical coherence tomography.

Tada T, Byrne RA, Schuster T, Cuni R, Kitabata H, Tiroch K, Dirninger A, Gratze F, Kaspar K, Zenker G, Joner M, Schömig A, Kastrati A.

Cardiovasc Revasc Med. 2013 Mar-Apr;14(2):84-9. doi: 10.1016/j.carrev.2012.12.003.

PMID:
23352095
17.

Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT.

Kim JS, Hong MK, Shin DH, Kim BK, Ko YG, Choi D, Jang Y.

JACC Cardiovasc Imaging. 2012 Nov;5(11):1147-55. doi: 10.1016/j.jcmg.2012.01.024.

18.

Different serial changes in the neointimal condition of sirolimus-eluting stents and paclitaxel-eluting stents: an optical coherence tomographic study.

Nakamura D, Lee Y, Yoshimura T, Taniike M, Makino N, Kato H, Egami Y, Shutta R, Tanouchi J, Yamada Y, Hara M, Sakata Y, Hamasaki T, Nishino M.

EuroIntervention. 2014 Dec;10(8):924-33. doi: 10.4244/EIJV10I8A159.

19.

Assessment by optical coherence tomography of stent struts across side branch. -Comparison of bare-metal stents and drug-elution stents.-.

Liu Y, Imanishi T, Kubo T, Tanaka A, Kitabata H, Tanimoto T, Ino Y, Ikejima H, Tsujioka H, Komukai K, Ishibashi K, Kashiwagi M, Ozaki Y, Hirata K, Mizukoshi M, Akasaka T.

Circ J. 2011;75(1):106-12.

20.

Long-term (≥2 years) follow-up optical coherence tomographic study after sirolimus- and paclitaxel-eluting stent implantation: comparison to 9-month follow-up results.

Kim TH, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Hong MK.

Int J Cardiovasc Imaging. 2011 Jul;27(6):875-81. doi: 10.1007/s10554-010-9729-6.

PMID:
20978851

Supplemental Content

Support Center